Ivermectin

Producers shown on SFDA

(Record date:08/09/2021）

Producers shown on EP

(Quoted from EP website；record date:08/09/2021）

Producer:Zhejiang Hisun Pharmaceutical Co., Ltd. was founded in 1956. In 2000, Hisun issued A-shares in Shanghai stock exchange, but it continues to remain a state-owned enterprise. Hisun is one of the largest antibiotics and anti-tumor drug production bases in the country. It has won several titles, including first batch of innovative enterprises, national technology innovation demonstration enterprises, and "National Industrial Brand Demonstration Enterprise” of the Chinese Ministry of Industry and Information Technology. 

Hisun began as a small chemical factory and entered the pharmaceutical field in the early 1970s. Since its founding over 60 years ago in 1956, Hisun has amassed a total asset worth of 21.8 billion RMB. While Hisun is primarily engaged in the R&D, manufacturing, and sales and marking of API and final dosage forms of chemical and biological drugs, its core business has extended to include branded generic drugs, biosimilarst and other innovative drugs. 

Staff size:About 9000 persns

Registered capital:RMB 1 billion 169 million

Producer:Hebei Veyong Pharmaceutical Co., Ltd.is the core enterprise of Weiyuan biochemistry and a large domestic veterinary drug double GMP certification enterprise producing veterinary APIs and preparations. The company has the largest production base of tamoxin in China, ivermectin in Asia and abamectin API in the world.
Staff size:300-399 persons

Registered capital:RMB 50 million

Producer:Shandong Qifa Pharmaceutical Co., Ltd. is a biopharmaceutical base invested by Qilu Pharmaceutical Co., Ltd. in 1987, mainly producing microbial drugs. The company covers an area of about 200000 square meters and produces more than 8000 tons of microbial drugs per year.

The company's main products have passed FDA, EDQM and APVMA certification.

Registered capital:RMB 73.33062 million

Producer:Ningxia Taiyicin Biotech Co., Ltd, established in June 2010, is a wholly-owned subsidiary of Ningxia Tairui Pharmaceutical Co., Ltd. the company is based on GMP certification, ISO9001 quality management system, ISO14001 environmental management system certification of the Ministry of agriculture, FDA certification, European CEP certification and quality audit certification of key enterprises in many countries and regions. At present, many products of the company have successfully passed the GMP certification of the Ministry of agriculture and obtained the veterinary drug production license.
Staff size:1000-1999 persons

Registered capital:RMB 625 million

Producer:Hebei Meihe Pharmaceutical Co., Ltd., founded in 2011, has 2600 square meters of production workshop, 300 square meters of laboratory, testing room and 400 square meters of fine drying charter room.

The annual production of ivermectin is 100 tons, acetylaminoavermectin is 10 tons and albendazole is 500 tons. The product standards are cvp2015 / ep9 / USP / CP, oxyalbendazole and albendazole ultrafine powder.

Registered capital:RMB 16 million

Producer:North China Pharmaceutical Group Aino Co., Ltd., a joint venture subsidiary controlled by North China Pharmaceutical Group, was founded in 1996. The company covers an area of more than 60000 square meters and a total construction area of more than 12000 square meters.

The company has passed GMP certification in China, ISO14001, FDA and COS certification in Europe. At present, the production capacity of avermectin and ivermectin has reached 130 tons and 30 tons respectively.

Registered capital:RMB 6660.560009 million